Other articles of interest

Epidemiology of atrial fibrillation-related ischemic stroke and its association with DOAC uptake in Spain: first national population-based study 2005 to 2018

Jaime Díaz-Guzmán, Román Freixa-Pamias, Javier García-Alegría, Alejandro-Isidoro Pérez Cabeza, Inmaculada Roldán-Rabadán, Beatriz Antolin-Fontes, Pablo Rebollo, Aleix Llorac, Mar Genís-Gironés, Carlos Escobar-Cervantes,

Rev Esp Cardiol. 2022;75:496-505
Cost and burden of poor anticoagulation control with vitamin K antagonists in patients with nonvalvular atrial fibrillation in Spain

Vivencio Barrios, Sergio Cinza-Sanjurjo, Olga Gavín, Isabel Egocheaga, Ramón Burgos-Pol, Javier Soto, Carlos Polanco, Jorge Suárez, Miguel Ángel Casado,

Rev Esp Cardiol. 2021;74:773-80
Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry

Aitor Uribarri, Iván J. Núñez-Gil, Álvaro Aparisi, Ramón Arroyo-Espliguero, Charbel Maroun Eid, Rodolfo Romero, Víctor M. Becerra-Muñoz, Gisela Feltes, María Molina, Marcos García-Aguado, Enrico Cerrato, Thamar Capel-Astrua, Emilio Alfonso-Rodríguez, Alex F. Castro-Mejía, Sergio Raposeiras-Roubín, Carolina Espejo, Nerea Pérez-Solé, Alfredo Bardají, Francisco Marín, Óscar Fabregat-Andrés, Fabrizio D¿ascenzo, Francesco Santoro, Ibrahim Akin, Vicente Estrada, Antonio Fernández-Ortiz, Carlos Macaya,

Rev Esp Cardiol. 2021;74:608-15